Blackstone Inc
AUTL

Blackstone Inc’s Autolus Therapeutics AUTL Stock Holding History

Blackstone Inc’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.8M Hold
20,485,611
– – 0.1% 61
2026
Q1 		$28.3M Hold
20,485,611
– – 0.11% 59
2025
Q4 		$40.8M Hold
20,485,611
– – 0.16% 56
2025
Q3 		$33.4M Hold
20,485,611
– – 0.13% 59
2025
Q2 		$46.7M Hold
20,485,611
– – 0.2% 45
2025
Q1 		$31.8M Hold
20,485,611
– – 0.13% 54
2024
Q4 		$48.1M Hold
20,485,611
– – 0.22% 44
2024
Q3 		$74.4M Hold
20,485,611
– – 0.32% 32
2024
Q2 		$71.3M Hold
20,485,611
– – 0.3% 35
2024
Q1 		$131M Hold
20,485,611
– – 0.53% 29
2023
Q4 		$132M Hold
20,485,611
– – 0.59% 29
2023
Q3 		$47.7M Hold
20,485,611
– – 0.2% 44
2023
Q2 		$48.8M Hold
20,485,611
– – 0.21% 45
2023
Q1 		$37.7M Hold
20,485,611
– – 0.15% 46
2022
Q4 		$38.9M Buy
20,485,611
+2,500,000
+14% +$6.32M 0.15% 44
2022
Q3 		$38.5M Hold
17,985,611
– – 0.14% 43
2022
Q2 		$50.9M Hold
17,985,611
– – 0.17% 42
2022
Q1 		$75M Hold
17,985,611
– – 0.19% 49
2021
Q4 		$93.3M Buy
+17,985,611
New +$108M 0.23% 54

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Blackstone Inc's AUTL Position: Q2 2026 in Review

Blackstone Inc held its Autolus Therapeutics (AUTL) position steady in Q2 2026 at 20,485,611 shares worth $32.8M. The position accounts for 0.1% of the portfolio, ranked #61.

Blackstone Inc first reported a position in AUTL in Q4 2021 and has held it in 19 quarters since. The position peaked at $132M in Q4 2023. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Blackstone Inc held 20,485,611 shares of Autolus Therapeutics worth $32.8M as of Q2 2026.
  • Blackstone Inc left its Autolus Therapeutics share count unchanged in Q2 2026.
  • Autolus Therapeutics made up 0.1% of Blackstone Inc's portfolio in Q2 2026, its #61 holding.
  • Blackstone Inc first reported a position in Autolus Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Blackstone Inc's Autolus Therapeutics position peaked at $132M in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.